Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services - NEC
- Sub-Industry: Health Care Services
- Symbol: NYSE:CHE
- CUSIP: 16359R10
- Web: www.chemed.com
Capitalization:- Market Cap: $3.26 billion
- Outstanding Shares: 16,082,000
Average Prices:- 50 Day Moving Avg: $205.37
- 200 Day Moving Avg: $189.24
- 52 Week Range: $130.05 - $216.01
P/E:- Trailing P/E Ratio: 29.73
- Foreward P/E Ratio: 23.93
- P/E Growth: 2.56
Sales & Book Value:- Annual Revenue: $1.59 billion
- Price / Sales: 2.05
- Book Value: $31.13 per share
- Price / Book: 6.51
Dividend:- Annual Dividend: $1.04
- Dividend Yield: 0.5%
Profitability:- EBIDTA: $217.5 million
- Net Margins: 7.14%
- Return on Equity: 24.62%
- Return on Assets: 14.04%
Debt:- Debt-to-Equity Ratio: 0.27%
- Current Ratio: 1.07%
- Quick Ratio: 1.04%
Misc:- Average Volume: 101,902 shs.
- Beta: 1.15
- Short Ratio: 16.02
Frequently Asked Questions for Chemed Corp. (NYSE:CHE)
What is Chemed Corp.'s stock symbol?
Chemed Corp. trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."
How often does Chemed Corp. pay dividends? What is the dividend yield for Chemed Corp.?
Chemed Corp. announced a quarterly dividend on Monday, May 15th. Stockholders of record on Thursday, May 25th will be paid a dividend of $0.26 per share on Wednesday, June 14th. This represents a $1.04 annualized dividend and a dividend yield of 0.51%. The ex-dividend date of this dividend is Tuesday, May 23rd. View Chemed Corp.'s Dividend History.
How will Chemed Corp.'s stock buyback program work?
Chemed Corp. declared that its Board of Directors has approved a share repurchase program on Monday, April 10th 2017, which authorizes the company to buyback $100,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 3.3% of its stock through open market purchases. Stock buyback programs are often an indication that the company's management believes its stock is undervalued.
How were Chemed Corp.'s earnings last quarter?
Chemed Corp. (NYSE:CHE) announced its quarterly earnings results on Wednesday, April, 26th. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.78 by $0.04. The company earned $405.90 million during the quarter, compared to analysts' expectations of $399.75 million. Chemed Corp. had a return on equity of 24.62% and a net margin of 7.14%. The business's revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.62 earnings per share. View Chemed Corp.'s Earnings History.
When will Chemed Corp. make its next earnings announcement?
What guidance has Chemed Corp. issued on next quarter's earnings?
Chemed Corp. updated its FY17 earnings guidance on Wednesday, April, 26th. The company provided EPS guidance of $7.80-$8.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.90.
Where is Chemed Corp.'s stock going? Where will Chemed Corp.'s stock price be in 2017?
3 equities research analysts have issued 12 month price targets for Chemed Corp.'s stock. Their forecasts range from $155.00 to $208.00. On average, they expect Chemed Corp.'s stock price to reach $181.50 in the next twelve months. View Analyst Ratings for Chemed Corp..
Who are some of Chemed Corp.'s key competitors?
Some companies that are related to Chemed Corp. include Mednax (MD), NMC Health PLC (NMC), Acadia Healthcare Company (ACHC), HealthSouth Corporation (HLS), Molina Healthcare (MOH), LifePoint Health (LPNT), Select Medical Holdings Corporation (SEM), Udg Healthcare PLC (UDG), Tenet Healthcare Corporation (THC), HMS Holdings Corp (HMSY), Community Health Systems (CYH), Kindred Healthcare (KND), China Cord Blood Corporation (CO), HealthStream (HSTM), American Renal Associates Holdings (ARA), Georgia Healthcare Group PLC (GHG), Cambian Group PLC (CMBN) and Concord Medical Services Holdings Limited (CCM).
Who are Chemed Corp.'s key executives?
Chemed Corp.'s management team includes the folowing people:
- George J. Walsh III, Independent Chairman of the Board
- Kevin J. McNamara, President, Chief Executive Officer, Director
- David Patrick Williams, Chief Financial Officer, Executive Vice President
- Spencer S. Lee, Executive Vice President
- Nicholas Michael Westfall, Executive Vice President
- Michael D. Witzeman, Principal Accounting Officer, Controller
- Thomas Charles Hutton, Director
- Joel F. Gemunder, Independent Director
- Patrick P. Grace, Independent Director
- Walter L. Krebs, Independent Director
Who owns Chemed Corp. stock?
Chemed Corp.'s stock is owned by many different of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (4.17%), Acadian Asset Management LLC (3.60%), Fisher Asset Management LLC (3.11%), Van Berkom & Associates Inc. (2.77%), BTIM Corp. (1.11%) and Russell Investments Group Ltd. (0.91%). Company insiders that own Chemed Corp. stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed Corp..
Who sold Chemed Corp. stock? Who is selling Chemed Corp. stock?
Chemed Corp.'s stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, BTIM Corp., Russell Investments Group Ltd., Van Berkom & Associates Inc., Fisher Asset Management LLC, Rockefeller Financial Services Inc., Boston Advisors LLC and US Bancorp DE. Company insiders that have sold Chemed Corp. stock in the last year include Arthur V Tucker Jr, Donald E Saunders, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed Corp..
Who bought Chemed Corp. stock? Who is buying Chemed Corp. stock?
Chemed Corp.'s stock was bought by a variety of institutional investors in the last quarter, including Copeland Capital Management LLC, Acadian Asset Management LLC, NN Investment Partners Holdings N.V., State of Alaska Department of Revenue, Aperio Group LLC, Cape Cod Five Cents Savings Bank, First Quadrant L P CA and Parametrica Management Ltd. Company insiders that have bought Chemed Corp. stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed Corp..
How do I buy Chemed Corp. stock?
Shares of Chemed Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemed Corp.'s stock price today?
One share of Chemed Corp. stock can currently be purchased for approximately $202.66.
MarketBeat Community Rating for Chemed Corp. (NYSE CHE)MarketBeat's community ratings are surveys of what our community members think about Chemed Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Chemed Corp. (NYSE:CHE) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Hold Ratings, 1 Buy Rating |
| Consensus Rating: | Hold (Score: 2.33) |
| Consensus Price Target: | $181.50 (10.44% downside) |
Analysts' Ratings History for Chemed Corp. (NYSE:CHE)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/5/2017 | Royal Bank Of Canada | Reiterated Rating | Hold | $208.00 | High |  |
| 9/27/2016 | Oppenheimer Holdings, Inc. | Reiterated Rating | Outperform | $155.00 | N/A | |
| 9/4/2016 | JMP Securities | Reiterated Rating | Hold | | N/A | |
| 9/15/2015 | Deutsche Bank AG | Reiterated Rating | Buy | | N/A | |
(Data available from 7/25/2015 forward)
Earnings History for Chemed Corp. (NYSE:CHE)Earnings History by Quarter for Chemed Corp. (NYSE CHE)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/25/2017 | Q2 2017 | $1.89 | | | | | N/A | |
| 4/26/2017 | Q1 2017 | $1.78 | $1.82 | $399.75 million | $405.90 million | View | N/A | |
| 2/15/2017 | Q416 | $2.10 | $2.10 | $409.89 million | $403.00 million | View | Listen | |
| 10/26/2016 | Q316 | $1.82 | $1.73 | $270.44 million | $392.61 million | View | Listen | |
| 7/25/2016 | Q216 | $1.72 | $1.80 | $393.50 million | $290.00 million | View | Listen | |
| 4/28/2016 | Q116 | $1.58 | $1.62 | $391.68 million | $390.40 million | View | Listen | |
| 2/17/2016 | Q415 | $1.81 | $1.97 | $390.22 million | $398.60 million | View | Listen | |
| 10/22/2015 | Q315 | $1.61 | $1.78 | $375.95 million | $386.23 million | View | Listen | |
| 7/23/2015 | Q215 | $1.59 | $1.71 | $375.01 million | $382.00 million | View | Listen | |
| 4/28/2015 | Q115 | $1.35 | $1.54 | $370.76 million | $377.00 million | View | Listen | |
| 2/17/2015 | Q414 | $1.65 | $1.80 | $372.54 million | $379.00 million | View | Listen | |
| 10/30/2014 | Q314 | $1.34 | $1.40 | $360.00 million | $358.40 million | View | Listen | |
| 7/23/2014 | Q214 | $1.31 | $1.50 | $363.73 million | $360.18 million | View | Listen | |
| 4/29/2014 | Q114 | $1.23 | $1.32 | $256.77 million | $358.30 million | View | Listen | |
| 10/29/2013 | Q313 | $1.34 | $1.36 | $355.40 million | $340.90 million | View | Listen | |
| 7/18/2013 | Q2 2013 | $1.33 | $1.44 | $368.06 million | $357.00 million | View | Listen | |
| 4/18/2013 | Q1 2013 | $1.29 | $1.38 | $365.08 million | $367.00 million | View | Listen | |
| 2/18/2013 | Q4 2012 | $1.15 | $1.57 | $355.31 million | $369.00 million | View | Listen | |
| 10/29/2012 | Q312 | $1.35 | $1.28 | $360.50 million | $354.00 million | View | N/A | |
| 7/25/2012 | | $1.26 | $1.26 | | | View | N/A | |
| 4/19/2012 | | $1.25 | $1.21 | | | View | N/A | |
| 2/14/2012 | | $1.48 | $1.45 | | | View | N/A | |
| 10/25/2011 | | $1.15 | $1.20 | | | View | N/A | |
| 4/26/2011 | | $0.98 | $1.07 | | | View | N/A | |
| 2/15/2011 | | $1.05 | $0.98 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Chemed Corp. (NYSE:CHE)2017 EPS Consensus Estimate: $7.93
2018 EPS Consensus Estimate: $8.49
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | $1.77 | $1.77 | $1.77 |
| Q2 2017 | 1 | $1.89 | $1.89 | $1.89 |
| Q3 2017 | 1 | $1.96 | $1.96 | $1.96 |
| Q4 2017 | 1 | $2.31 | $2.31 | $2.31 |
| Q1 2018 | 1 | $1.92 | $1.92 | $1.92 |
| Q2 2018 | 1 | $2.03 | $2.03 | $2.03 |
| Q3 2018 | 1 | $2.10 | $2.10 | $2.10 |
| Q4 2018 | 1 | $2.44 | $2.44 | $2.44 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Chemed Corp. (NYSE:CHE)| Most Recent Dividend: | 6/14/2017 |
| Annual Dividend: | $1.04 |
| Dividend Yield: | 0.51% |
| Dividend Growth: | 9.60% (3 Year Average) |
| Payout Ratio: | 15.25% (Trailing 12 Months of Earnings)
13.08% (Based on This Year's Estimates)
12.28% (Based on Next Year's Estimates)
|
| Track Record: | 8 Years of Consecutive Dividend Growth |
Dividend History by Quarter for Chemed Corp. (NYSE CHE)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 5/15/2017 | Quarterly | $0.26 | 0.51% | 5/23/2017 | 5/25/2017 | 6/14/2017 |
| 2/17/2017 | quarterly | $0.26 | 0.59% | 2/23/2017 | 2/27/2017 | 3/20/2017 |
| 11/4/2016 | quarterly | $0.26 | 0.76% | 11/9/2016 | 11/14/2016 | 12/5/2016 |
| 8/5/2016 | quarterly | $0.26 | 0.72% | 8/11/2016 | 8/15/2016 | 9/2/2016 |
| 5/16/2016 | quarterly | $0.24 | 0.76% | 5/24/2016 | 5/26/2016 | 6/15/2016 |
| 2/19/2016 | quarterly | $0.24 | 0.75% | 2/25/2016 | 2/29/2016 | 3/21/2016 |
| 11/6/2015 | quarterly | $0.24 | 0.63% | 11/12/2015 | 11/16/2015 | 12/7/2015 |
| 8/7/2015 | quarterly | $0.24 | 0.63% | 8/13/2015 | 8/17/2015 | 9/4/2015 |
| 5/18/2015 | quarterly | $0.22 | 0.71% | 5/26/2015 | 5/28/2015 | 6/17/2015 |
| 2/20/2015 | quarterly | $0.22 | 0.77% | 2/26/2015 | 3/2/2015 | 3/23/2015 |
| 11/7/2014 | quarterly | $0.22 | 0.81% | 11/13/2014 | 11/17/2014 | 12/8/2014 |
| 8/11/2014 | quarterly | $0.22 | 0.88% | 8/14/2014 | 8/18/2014 | 9/13/2014 |
| 8/8/2014 | quarterly | $0.22 | | 8/14/2014 | 8/18/2014 | 9/3/2014 |
| 5/19/2014 | quarterly | $0.20 | 0.91% | 5/27/2014 | 5/29/2014 | 6/18/2014 |
| 2/21/2014 | quarterly | $0.20 | 0.94% | 2/27/2014 | 3/3/2014 | 3/24/2014 |
| 11/8/2013 | quarterly | $0.20 | 1.13% | 11/14/2013 | 11/18/2013 | 12/9/2013 |
| 8/2/2013 | quarterly | $0.20 | 1.1% | 8/8/2013 | 8/12/2013 | 9/3/2013 |
| 5/20/2013 | quarterly | $0.18 | 1.05% | 5/28/2013 | 5/30/2013 | 6/19/2013 |
| 2/20/2013 | quarterly | $0.18 | 0.92% | 2/28/2013 | 3/4/2013 | 3/22/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Chemed Corp. (NYSE:CHE)Insider Ownership Percentage: 5.32%
Institutional Ownership Percentage: 98.57%
Insider Trades by Quarter for Chemed Corp. (NYSE:CHE)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/26/2017 | George J Walsh III | Director | Buy | 1,000 | $204.56 | $204,560.00 | |
| 5/4/2017 | Donald E Saunders | Director | Buy | 94 | $205.59 | $19,325.46 | |
| 5/3/2017 | Donald E Saunders | Director | Sell | 400 | $204.85 | $81,940.00 | |
| 5/2/2017 | Kevin J Mcnamara | Insider | Sell | 4,000 | $205.11 | $820,440.00 | |
| 5/1/2017 | Spencer S Lee | Insider | Sell | 1,000 | $202.47 | $202,470.00 | |
| 3/3/2017 | Kevin J Mcnamara | Insider | Sell | 7,000 | $181.74 | $1,272,180.00 | |
| 3/2/2017 | Arthur V Tucker Jr | VP | Sell | 2,266 | $181.00 | $410,146.00 | |
| 2/27/2017 | Arthur V Tucker Jr | VP | Sell | 8,878 | $179.21 | $1,591,026.38 | |
| 2/24/2017 | Kevin J Mcnamara | Insider | Sell | 7,000 | $177.63 | $1,243,410.00 | |
| 11/28/2016 | Patrick P Grace | Director | Sell | 400 | $148.53 | $59,412.00 | |
| 11/14/2016 | Donald E Saunders | Director | Sell | 500 | $149.56 | $74,780.00 | |
| 11/14/2016 | Spencer S Lee | Insider | Sell | 4,500 | $150.22 | $675,990.00 | |
| 10/31/2016 | Kevin J Mcnamara | Insider | Sell | 10,000 | $138.40 | $1,384,000.00 | |
| 9/22/2016 | Spencer S Lee | Insider | Sell | 2,000 | $141.67 | $283,340.00 | |
| 8/8/2016 | Donald E Saunders | Director | Sell | 500 | $144.32 | $72,160.00 | |
| 8/5/2016 | Arthur V Tucker Jr | VP | Sell | 4,500 | $144.28 | $649,260.00 | |
| 8/4/2016 | Arthur V Tucker Jr | VP | Sell | 3,089 | $143.88 | $444,445.32 | |
| 8/3/2016 | Kevin J Mcnamara | Insider | Sell | 18,000 | $144.87 | $2,607,660.00 | |
| 5/16/2016 | Donald E Saunders | Director | Buy | 77 | $126.53 | $9,742.81 | |
| 3/21/2016 | Spencer S Lee | EVP | Sell | 24,382 | $132.29 | $3,225,494.78 | |
| 1/27/2016 | Patrick P Grace | Director | Sell | 50 | $138.98 | $6,949.00 | |
| 12/11/2015 | David Patrick Williams | CFO | Sell | 5,000 | $151.72 | $758,600.00 | |
| 11/24/2015 | Spencer S Lee | EVP | Sell | 5,000 | $154.10 | $770,500.00 | |
| 11/6/2015 | Kevin J Mcnamara | CEO | Sell | 6,000 | $157.02 | $942,120.00 | |
| 10/27/2015 | Spencer S. Lee | EVP | Sell | 4,000 | $153.64 | $614,560.00 | |
| 10/26/2015 | Kevin J. Mcnamara | CEO | Sell | 8,000 | $149.04 | $1,192,320.00 | |
| 8/24/2015 | David Patrick Williams | CFO | Sell | 10,000 | $138.09 | $1,380,900.00 | |
| 5/15/2015 | Arthur V Tucker Jr | VP | Sell | 9,000 | $121.00 | $1,089,000.00 | |
| 5/7/2015 | Kevin J Mcnamara | CEO | Sell | 8,000 | $120.82 | $966,560.00 | |
| 3/6/2015 | Spencer S Lee | EVP | Sell | 9,931 | $115.16 | $1,143,653.96 | |
| 3/2/2015 | Timothy S Otoole | EVP | Sell | 10,000 | $117.82 | $1,178,200.00 | |
| 2/27/2015 | Arthur V Tucker Jr | VP | Sell | 7,000 | $116.80 | $817,600.00 | |
| 2/24/2015 | Arthur V Tucker Jr | VP | Sell | 2,685 | $114.35 | $307,029.75 | |
| 2/23/2015 | Spencer S Lee | EVP | Sell | 10,000 | $113.18 | $1,131,800.00 | |
| 2/20/2015 | Kevin J Mcnamara | CEO | Sell | 13,000 | $112.71 | $1,465,230.00 | |
| 11/14/2014 | Timothy S Otoole | EVP | Sell | 5,000 | $106.81 | $534,050.00 | |
| 11/13/2014 | Spencer S Lee | EVP | Sell | 10,000 | $108.38 | $1,083,800.00 | |
| 11/4/2014 | Kevin J Mcnamara | CEO | Sell | 4,000 | $104.13 | $416,520.00 | |
| 9/10/2014 | Spencer S Lee | EVP | Sell | 2,000 | $105.80 | $211,600.00 | |
| 9/8/2014 | David Patrick Williams | CFO | Sell | 5,000 | $105.90 | $529,500.00 | |
| 8/7/2014 | Kevin J Mcnamara | CEO | Sell | 5,000 | $100.05 | $500,250.00 | |
| 7/25/2014 | Arthur V Tucker Jr | VP | Sell | 9,000 | $101.26 | $911,340.00 | |
| 7/25/2014 | Kevin J Mcnamara | CEO | Sell | 10,000 | $101.00 | $1,010,000.00 | |
| 5/15/2014 | Timothy Otoole | EVP | Sell | 9,000 | $87.62 | $788,580.00 | |
| 5/5/2014 | Kevin Mcnamara | CEO | Sell | 5,000 | $85.05 | $425,250.00 | |
| 4/2/2014 | Spencer Lee | EVP | Sell | 2,000 | $90.15 | $180,300.00 | |
| 3/19/2014 | Thomas Hutton | VP | Sell | 2,201 | $88.36 | $194,480.36 | |
| 3/11/2014 | Timothy Otoole | EVP | Sell | 6,000 | $86.60 | $519,600.00 | |
| 3/3/2014 | Kevin Mcnamara | CEO | Sell | 4,000 | $84.47 | $337,880.00 | |
| 2/28/2014 | Arthur Tucker, Jr. | VP | Sell | 9,000 | $85.01 | $765,090.00 | |
| 2/25/2014 | Arthur Tucker, Jr. | VP | Sell | 8,461 | $83.80 | $709,031.80 | |
| 2/20/2014 | Spencer Lee | EVP | Sell | 2,000 | $82.51 | $165,020.00 | |
| 2/19/2014 | Kevin Mcnamara | CEO | Sell | 4,000 | $82.18 | $328,720.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Chemed Corp. (NYSE:CHE)
Latest Headlines for Chemed Corp. (NYSE:CHE)
| Source: |
|
| Date | Headline |
|---|
 | Chemed Reports Second-Quarter 2017 Results
finance.yahoo.com - July 25 at 5:05 PM |
| ETFs with exposure to Chemed Corp. : July 24, 2017
finance.yahoo.com - July 24 at 4:44 PM |
| Chemed Corp. breached its 50 day moving average in a Bearish Manner : CHE-US : July 19, 2017
finance.yahoo.com - July 19 at 3:42 PM |
 | Chemed Corp. (NYSE:CHE) to Release Earnings on Tuesday
www.americanbankingnews.com - July 18 at 8:36 AM |
| ETFs with exposure to Chemed Corp. : July 13, 2017
finance.yahoo.com - July 13 at 6:11 PM |
| Chemed Corp. – Value Analysis (NYSE:CHE) : July 10, 2017
finance.yahoo.com - July 10 at 5:05 PM |
| Chemed To Report Second-Quarter 2017 Earnings July 25, Related Conference Call To Be Held On July 26
finance.yahoo.com - July 10 at 5:05 PM |
| Chemed Corp. breached its 50 day moving average in a Bearish Manner : CHE-US : July 7, 2017
finance.yahoo.com - July 8 at 9:45 AM |
| Chemed Corp. (NYSE:CHE) Given "Hold" Rating at Royal Bank Of Canada
www.americanbankingnews.com - July 5 at 9:20 PM |
| Chemed Corp. (CHE) Director Acquires $204,560.00 in Stock
www.americanbankingnews.com - June 26 at 1:22 PM |
| Chemed Corp. (CHE) Rating Lowered to Buy at BidaskClub
www.americanbankingnews.com - June 24 at 2:26 PM |
| New COO takes over at Cincinnati-owned health care firm
finance.yahoo.com - June 20 at 4:54 PM |
| Chemed Corp. (CHE) and Almost Family (AFAM) Head to Head Comparison
www.americanbankingnews.com - June 13 at 7:45 AM |
| Head-To-Head Review: Amedisys (AMED) & Chemed (CHE)
www.americanbankingnews.com - June 4 at 4:50 PM |
| Chemed Corporation to Present at the Jefferies 2017 Global Healthcare Conference
finance.yahoo.com - May 31 at 4:19 PM |
| Chemed Co. (che) to Issue $0.26 Quarterly Dividend
www.americanbankingnews.com - May 16 at 10:22 AM |
| Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend
finance.yahoo.com - May 15 at 4:01 PM |
| Chemed Corporation to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
finance.yahoo.com - May 11 at 4:54 PM |
| Insider Buying: Chemed Co. (CHE) Director Acquires 94 Shares of Stock
www.americanbankingnews.com - May 5 at 5:14 PM |
| Chemed Co. (CHE) Director Sells $81,940.00 in Stock
www.americanbankingnews.com - May 5 at 4:51 PM |
| Favorable News Coverage Unlikely to Affect Chemed (CHE) Share Price
www.americanbankingnews.com - May 4 at 5:14 PM |
| Chemed Co. (CHE) Insider Sells $820,440.00 in Stock
www.americanbankingnews.com - May 2 at 6:46 PM |
| Spencer S. Lee Sells 1,000 Shares of Chemed Co. (CHE) Stock
www.americanbankingnews.com - May 1 at 8:24 PM |
| Chemed Corp. :CHE-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017
finance.yahoo.com - May 1 at 4:14 PM |
| Oppenheimer Holdings Weighs in on Chemed Co.'s Q3 2018 Earnings (CHE)
www.americanbankingnews.com - May 1 at 1:04 PM |
| Favorable Press Coverage Somewhat Unlikely to Affect Chemed (CHE) Stock Price
www.americanbankingnews.com - April 29 at 5:47 PM |
| Edited Transcript of CHE earnings conference call or presentation 27-Apr-17 2:00pm GMT
finance.yahoo.com - April 28 at 5:14 PM |
| Chemed Reports First-Quarter 2017 Results
finance.yahoo.com - April 27 at 4:43 PM |
| Chemed Co. (CHE) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS
www.americanbankingnews.com - April 27 at 12:20 AM |
| Chemed Co. (CHE) Announces Earnings Results
www.americanbankingnews.com - April 26 at 11:24 PM |
| Chemed (CHE) Earns Daily News Sentiment Score of 0.34
www.americanbankingnews.com - April 26 at 9:00 PM |
| Chemed Co. (CHE) Releases FY17 Earnings Guidance
www.americanbankingnews.com - April 26 at 6:49 PM |
 | Chemed posts 1Q profit
marketbeat.com - April 26 at 6:28 PM |
| Chemed (CHE) Given Daily News Impact Rating of 0.31
www.americanbankingnews.com - April 20 at 4:11 PM |
 | EXCLUSIVE: How Facebook fueled the Courier's stock contest leader
www.bizjournals.com - April 17 at 4:06 PM |
| Chemed (CHE) Earning Somewhat Critical News Coverage, Study Finds
www.americanbankingnews.com - April 17 at 2:54 PM |
| Chemed (CHE) Earns Media Impact Score of 0.50
www.americanbankingnews.com - April 14 at 9:21 AM |
| Chemed (CHE) Board of Directors Initiates Share Buyback Plan
www.americanbankingnews.com - April 10 at 9:14 AM |
| Chemed To Report First-Quarter 2017 Earnings April 26, Related Conference Call To Be Held On April 27
finance.yahoo.com - April 7 at 8:58 AM |
| CHEMED CORP Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - April 3 at 4:40 PM |
| Chemed (CHE) Up 6.4% Since Earnings Report: Can It Continue?
finance.yahoo.com - March 21 at 8:01 AM |
| Chemed Corporation to Present at the Oppenheimer 27th Annual Healthcare Conference
finance.yahoo.com - March 15 at 4:38 PM |
| 8:30 am Chemed's Board authorizes an additional $100 million for stock repurchase under its existing share repurchase program
finance.yahoo.com - March 13 at 12:43 PM |
| Chemed Corporation’s Board of Directors Authorizes an Additional $100 Million for Stock Repurchase
finance.yahoo.com - March 13 at 12:43 PM |
| CHEMED CORP Files SEC form 8-K, Other Events
biz.yahoo.com - March 13 at 12:43 PM |
| CHEMED CORP Financials
finance.yahoo.com - March 3 at 4:17 PM |
| CHEMED CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - February 27 at 2:49 PM |
 | Edited Transcript of CHE earnings conference call or presentation 16-Feb-17 3:00pm GMT
us.rd.yahoo.com - February 17 at 5:56 PM |
 | Chemed Corp. :CHE-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017
us.rd.yahoo.com - February 17 at 5:56 PM |
| CHEMED CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
biz.yahoo.com - February 17 at 5:56 PM |
Chemed Corp. (CHE) Chart for Tuesday, July, 25, 2017
